RICHELDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.940
EU - Europa 6.074
AS - Asia 1.806
SA - Sud America 29
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 16
Totale 21.907
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.886
GB - Regno Unito 2.351
IT - Italia 1.215
SE - Svezia 767
CN - Cina 739
DE - Germania 504
UA - Ucraina 474
TR - Turchia 279
HK - Hong Kong 273
FI - Finlandia 261
SG - Singapore 260
BG - Bulgaria 165
FR - Francia 165
IN - India 69
RU - Federazione Russa 48
CA - Canada 44
ID - Indonesia 44
KR - Corea 29
VN - Vietnam 28
BE - Belgio 26
IR - Iran 22
ZA - Sudafrica 19
IE - Irlanda 15
PK - Pakistan 14
AU - Australia 13
EU - Europa 13
NL - Olanda 13
IQ - Iraq 12
MY - Malesia 10
BR - Brasile 9
PL - Polonia 9
AL - Albania 8
JP - Giappone 8
MX - Messico 8
CH - Svizzera 7
TW - Taiwan 7
CL - Cile 6
TH - Thailandia 6
CZ - Repubblica Ceca 5
ES - Italia 5
LT - Lituania 5
NG - Nigeria 5
RO - Romania 5
CO - Colombia 4
GR - Grecia 4
HR - Croazia 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
BO - Bolivia 2
BZ - Belize 2
DK - Danimarca 2
EC - Ecuador 2
LV - Lettonia 2
MG - Madagascar 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
EE - Estonia 1
KH - Cambogia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 21.907
Salva come PNG Salva come JPEG
Città #
Fairfield 2.176
Southend 2.014
Woodbridge 1.472
Houston 1.133
Ashburn 1.098
Jacksonville 955
Chandler 921
Seattle 813
Dearborn 752
Wilmington 707
Ann Arbor 696
Cambridge 690
Nyköping 452
Hong Kong 267
Beijing 234
San Diego 191
Modena 182
Princeton 172
Sofia 164
Singapore 162
Eugene 158
Izmir 123
New York 108
Helsinki 104
London 66
Milan 59
Des Moines 57
Shanghai 57
Palermo 50
Redwood City 49
Bremen 46
Naples 45
Rome 44
Boardman 34
Jakarta 33
Norwalk 28
Phoenix 28
Brussels 26
Dong Ket 26
Hefei 26
Frankfurt am Main 23
Florence 22
Guangzhou 21
Bari 20
Kunming 20
Falls Church 19
San Mateo 19
Turin 18
Leawood 17
San Francisco 17
Chicago 15
Nanjing 15
Philadelphia 15
Jinan 14
Bologna 13
Dublin 13
Indiana 13
Kilburn 13
Mountain View 13
Verona 13
Hounslow 12
Mumbai 11
Los Angeles 10
Nanchang 10
Ottawa 10
Pescara 10
Toronto 10
Wuhan 10
Chennai 9
Chiswick 9
Holly 9
Seongnam 9
Lucca 8
San Jose 8
Tirana 8
Zhengzhou 8
Lahore 7
Napoli 7
Perugia 7
Pistoia 7
Saint Petersburg 7
Seoul 7
Andover 6
Auburn Hills 6
Basrah 6
Catania 6
Dallas 6
Durban 6
Hangzhou 6
Lusciano 6
Paris 6
Pioltello 6
Washington 6
Ardabil 5
Brisbane 5
Campobasso 5
Carini 5
Chongqing 5
Fuzhou 5
Gurgaon 5
Totale 17.045
Salva come PNG Salva come JPEG
Nome #
Malattie infiltrative diffuse del polmone 783
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 671
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 289
Non-steroid agents for idiopathic pulmonary fibrosis 268
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 260
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 227
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 227
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 220
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 218
Atypical lipomatous tumour (lipoma-like well-differentiated liposarcoma) arising in a pulmonary hamartoma and clinically presenting with pneumothorax 211
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 211
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts 203
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis 203
Aortic pulse wave velocity measurement in systemic sclerosis patients. 200
A culture-proven case of community-acquired Legionella pneumonia apparently classified as nosocomial: diagnostic and public health implications 195
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 189
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 186
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis 185
Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient 184
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 184
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 183
Amyotrophic lateral sclerosis and sarcoidosis: a difficult differential diagnosis. 181
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 180
Unexpected identification of bilateral masses in an asymptomatic heavy smoker. 179
Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis. 179
A quantitative proteomic approach to identify significantly altered protein networks in the serum of patients with lymphangioleiomyomatosis (LAM) 179
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 178
Pulmonary fibrosis and the many faces of UIP 178
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 177
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis 177
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials 174
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 174
Rifabutin for treating pulmonary tuberculosis. 173
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 168
Novel drug targets for idiopathic pulmonary fibrosis 168
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 167
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 166
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. 166
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 165
Management of Idiopathic Pulmonary Fibrosis 163
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 162
Sarcoidosis: challenging diagnostic aspects of an old disease. 160
Smoking-related interstitial lung disease 160
Environmental triggers and susceptibility factors in idiopathic granulomatous diseases. 160
Emerging drugs for idiopathic pulmonary fibrosis. 159
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 159
Management of idiopathic pulmonary fibrosis. 159
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 156
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 153
The big clinical trials in idiopathic pulmonary fibrosis. 153
Prevalence and prognosis of unclassifiable interstitial lung disease 151
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias 150
Macrolides in the treatment of asthma and cystic fibrosis 149
MOLECULAR DIAGNOSIS OF TUBERCULOSIS 148
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. 146
Treating idiopathic pulmonary fibrosis: current opportunities and future challenges. 145
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 145
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 144
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 144
Immunomodulatory agents for idiopathic pulmonary fibrosis. 142
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. 142
Idiopathic pulmonary fibrosis: current challenges and future perspectives 142
Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good 142
Genetic testing in diffuse parenchymal lung disease 141
Role of the quantiferon-TB test in ruling out pleural tuberculosis: a multi-centre study. 139
The role of biomarkers in low respiratory tract infections. 138
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 138
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 138
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 138
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis 137
Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis 136
Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program. 135
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 135
End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis. 134
To BAL or not to BAL: is this a problem in diagnosing IPF? 131
Early diagnosis of subclinical multi drug-resistant tuberculosis 129
Inappropriatezza prescrittiva dell'ossigenoterapia domiciliare a lungo termine 129
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. 128
The complex interrelationships between chronic lung and liver disease: a review. 127
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. 126
Screening dell’infezione tubercolare latente in operatori sanitari con QuantiFERON-TB e test cutaneo tubercolinico [Screening of latent tuberculosis infection in health care workers by QuantiFERON-TB and tuberculin skin test] 126
Interferon gamma assays for tuberculosis 124
Immunogenetic basis of environmental lung disease: lessons from the berylliosis model 124
HLA-DPB1 Glutamate 69: a genetic marker of beryllium disease 124
Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice 124
Il cloroformio nell'aria alveolare di frequentatori di piscine coperte. 124
Churg-Strauss syndrome in a case of asthma 124
Idiopathic pulmonary fibrosis: recent trials and current drug therapy 124
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 123
An update on the diagnosis of tuberculosis infection 122
Tuberculosis infection in foreign-born children: a screening survey based on skin and blood testing. 122
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial 122
Macrolides for chronic asthma. 121
Tuberculosis diagnostic tests: Sensitivity, specificity, and comparing apples with apples 120
Challenges in idiopathic interstitial lung disease 120
Tubercolosi 119
Interaction of genetic and exposure factors in the prevalence of berylliosis 116
Mycobacterium tuberculosis induces CCL18 expression in human macrophages 116
Macrolides for chronic asthma. 115
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 115
Totale 16.964
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.496 0 0 0 328 613 839 921 521 519 190 302 263
2020/20213.561 347 180 355 291 366 262 292 444 165 417 243 199
2021/20222.903 86 488 275 221 59 87 200 108 293 208 525 353
2022/20232.694 324 274 169 241 317 402 47 292 331 81 116 100
2023/20242.023 62 129 124 173 372 244 245 244 67 47 128 188
2024/2025482 212 90 84 96 0 0 0 0 0 0 0 0
Totale 22.102